ANDA 85038, held by Eli Lilly. Quinidine Sulfate.
As of Nov 21, 2026, ANDA 85038 (Quinidine Sulfate), held by Eli Lilly, was first approved by FDA on Jul 8, 1976, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 8, 1976 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Quinidine Sulfate200MG · tablet;oral | Quinidine Sulfate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters